05:57:49Philippines

DBV Technologies S.A. (DBVTF)

OTC Markets

Key stats Fiscal year 2025

Income statement

Revenue
5,636,000 35.8%
Net income
-146,947,000
Operating income
-147,056,000
Earnings per share
-1.05
R&D expense
116,682,000

Growth and profitability

Operating margin
-2,609.23
Net margin
-2,607.29
Return on equity
-87.07
Return on assets
-62.87
Free cash flow margin
-2,159.56

Balance sheet

Total assets
233,718,000
Total liabilities
64,948,000
Shareholders' equity
168,770,000
Cash and equivalents
194,167,000
Current ratio
3.67

Cash flow and ratios

Operating cash flow
-121,181,000
Free cash flow
-121,713,000

Shareholder returns

Shares outstanding
314,388,807
Book value per share
0.54
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Chatillon
Exchange
OTC Markets
Fiscal year end
12-31
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

DBV Technologies S.A. trades on OTC Markets under the ticker symbol DBVTF. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis